Skip to main content
SpringerLink
Log in

Baroreflex Stimulation in Antihypertensive Treatment

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Hypertension is a leading cause of morbidity and mortality worldwide. Despite the development of new medications, an alarmingly high proportion of patients are not reaching their target blood pressure goals, so nonpharmacologic therapies have been attracting more interest. Chronic baroreceptor stimulation of the carotid sinus has been shown to reduce blood pressure by inhibiting the sympathetic nervous system, particularly the renal sympathetic tone. This finding has led to the development of implantable carotid sinus stimulators, which have now been studied in both animals and humans, as a means for treating chronic hypertension. The enthusiasm for this modality has led to ongoing studies, which will provide more information on its safety and efficacy in patients with resistant hypertension. The early study results using baroreflex stimulation therapy are promising and suggest that it may play a significant role in controlling blood pressure in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as:•Of importance •• Of major importance

  1. Wolf-Maier K, Cooper RS, Banegas JR, et al.: Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003, 289:2362–2369.

    Article  Google Scholar 

  2. Rosamond W, Flegal K, Furie K, et al.: Heart disease and stroke statistics 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008, 117:e76–e80.

    Google Scholar 

  3. Blood Pressure Lowering Treatment Trialists’ Collaboration, Turnbull F, Neal B, et al.: Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomized trials. BMJ 2008,336:1121–1123.

    Article  CAS  PubMed  Google Scholar 

  4. Lewington S, Clarke R, Qizilbash N, et al.: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903–1913.

    Article  PubMed  Google Scholar 

  5. World Health Organization: World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva, Switzerland: World Health Organization, 2002.

    Google Scholar 

  6. Ong KL, Cheung BM, Man YB, et al.: Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension 2007, 49:69–75.

    Article  CAS  PubMed  Google Scholar 

  7. Wolf-Maier K, Cooper RS, Kramer H, et al.: Hypertension treatment and control in 5 European countries, Canada, and the United States. Hypertension 2004, 43:10–17.

    Article  CAS  PubMed  Google Scholar 

  8. Chobanian AV, Bakris GL, Black HR, et al.: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206–1252.

    Article  CAS  PubMed  Google Scholar 

  9. Calhoun DA, Jones D, Textor S, et al.: Resistant hypertension: diagnosis, evaluation and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008, 117:e510–e526.

    Article  PubMed  Google Scholar 

  10. •• Filippone JD, Bisognano JD: Baroreflex stimulation in the treatment of hypertension. Curr Opin Nephrol Hypertens 2007, 16:403–408. This article provides a good background on the history and development of baroreflex-stimulating technology.

    PubMed  Google Scholar 

  11. Braunwald E, Zipes D, Lippy P: Heart Disease, A Textbook of Cardiovascular Medicine. Philadelphia: WB Saunders; 2001:2173.

    Google Scholar 

  12. Lohmeier TE, Hildebrandt DA, Warren S, et al.: Recent insights into the interactions between the baroreflex and the kidneys in hypertension. Am J Physiol Regul Integr Comp Physiol 2005, 288:R828–R836.

    CAS  PubMed  Google Scholar 

  13. •• Chapleau MW: Arterial baroreflexes. In Hypertension Primer: The Essentials of High Blood Pressure, edn 4. Edited by Izzo JL, Black HR. Philadelphia: Lippincott Williams & Wilkins; 2007:120–122. This book chapter provides a detailed discussion about baroreflex physiology, particularly its effects on the neurohormonal system.

    Google Scholar 

  14. Rooke T, Sparks H Jr: Control mechanisms in circulatory function. In Medical Physiology, edn 2. Edited by Rhoades RA, Tanner GA. London: Lippincott Williams & Wilkins; 2003:290–303.

    Google Scholar 

  15. McCubbin JW, Green JH, Page IH: Baroreceptor function in chronic renal hypertension. Circ Res 1956, 4:205–210.

    CAS  PubMed  Google Scholar 

  16. Carlsten A, Folkow B, Grimby G, et al.: Cardiovascular effects of direct stimulation of the carotid sinus nerve in man. Acta Physiol Scand 1958, 44:138–145.

    Article  CAS  PubMed  Google Scholar 

  17. Bristow JD, Honour AJ, Pickering GW, et al.: Diminished baroreflex sensitivity in high blood pressure. Circulation 1969, 39:48–54.

    CAS  PubMed  Google Scholar 

  18. Warner HR: The frequency-dependent nature of blood pressure regulation by the carotid sinus studies with an electrical analog. Circ Res 1958, 6:35–40.

    CAS  PubMed  Google Scholar 

  19. Bilgutay A, Lillehei W: Treatment of hypertension with an implantable electronic device. JAMA 1965, 191:649–653.

    CAS  PubMed  Google Scholar 

  20. Bilgutay A, Lillehei W: Surgical treatment of hypertension with reference to baropacing. Am J Cardiol 1966, 17:663–667.

    Article  CAS  PubMed  Google Scholar 

  21. Schwartz S, Griffith L, Neistadt A, Hagfors N: Chronic carotid sinus nerve stimulation in the treatment of essential hypertension. Am J Surg 1967, 114:5–15.

    Article  CAS  PubMed  Google Scholar 

  22. Tuckman J, Reichman T, Lyon A, et al.: Electrical stimulation of the sinus nerves in hypertensive patients: clinical evaluation and physiological studies. Hypertension 1967, 194S:23–28.

    Google Scholar 

  23. Lohmeier TE, Lohmeier JR, Haque A, Hildebrandt DA: Baroreflexes prevent neurally induced sodium retention in angiotensin hypertension. Am J Physiol Regul Integr Comp Physiol 2000, 279(4):R1437–R1448.

    CAS  PubMed  Google Scholar 

  24. Lohmeier TE, Irwin E, Rossing M, et al.: Prolonged activation of the baroreflex produces sustained hypotension. Hypertension 2004, 43:306–311.

    Article  CAS  PubMed  Google Scholar 

  25. Barrett CJ, Guild SJ, Ramchandra R, Maplas SC: Baroreceptor denervation prevents sympathoinhibition during angiotensin II-induced hypertension. Hypertension 2005, 46:1–5.

    Article  Google Scholar 

  26. Lohmeier TE, Dwyer TM, Irwin ED, et al.: Prolonged activation of the baroreflex abolishes obesity-induced hypertension. Hypertension 2007, 49:1307–1314.

    Article  CAS  PubMed  Google Scholar 

  27. Lohmeier TE, Hildebrandt DA, Dwyer TM: Renal denervation does not abolish sustained baroreflex-mediated reductions in arterial pressure. Hypertension 2007, 49:373–379.

    Article  CAS  PubMed  Google Scholar 

  28. Uppuluri SC, Storozynsky E, Bisognano JD: Baroreflex device therapy in the treatment of hypertension. Curr Hypertens Rep 2009, 11:69–75.

    Article  PubMed  Google Scholar 

  29. Lohmeier TE, Barrett AM, Irwin ED: Prolonged activation of the baroreflex: a viable approach for the treatment of hypertension? Curr Hypertens Rep 2005, 7:193–198.

    Article  PubMed  Google Scholar 

  30. Tordoir JHM, Scheffers I, Schmidli J, et al.: An implantable carotid sinus baroreflex activating system: surgical technique and short-term outcome from a multicenter feasibility trial for the treatment of resistant hypertension. Eur J Vasc Endovasc Surg 2007, 33:414–421.

    Article  CAS  PubMed  Google Scholar 

  31. Illig KA, Levy M, Sanchez L, et al.: An implantable carotid sinus stimulator for drug resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos Feasibility Trial. J Vasc Surg 2006, 44:1213–1218.

    Article  PubMed  Google Scholar 

  32. Bisognano J, Sloand J, Papademetriou V, et al.: An implantable carotid sinus baroreflex activating system for drug-resistant hypertension: interim chronic efficacy results from the multicenter Rheos Feasibility Trial. Circulation 2006, 114(18 Suppl):II575.

    Google Scholar 

  33. Scheffers I, Schmidli J, Kroon AA, et al.: Sustained blood pressure reduction by baroreflex hypertension therapy with a chronically implanted system: 2-year data from the Rheos DEBuT-HT study in patients with resistant hypertension. J Hypertens 2008, 26(Suppl I):S19.

    Google Scholar 

  34. Scheffers I, Schmidli J, Kroon AA, et al.: Sustained blood pressure reduction by baroreflex hypertension therapy with a chronically implanted system: 3-year data from the Rheos DEBuT study in patients with resistant hypertension. J Hypertens 2009, 27(Suppl 4):S421.

    Google Scholar 

  35. Rothstein M, de Leeuw P, Elletson M; The DEBuT and Rheos Feasibility Investigators: Chronic treatment of resistant hypertension with an implantable device: interim 2 year results of two studies of the Rheos hypertension system [abstract]. Presented at the American College of Cardiology 58th Annual Scientific Session. Orlando, FL; March 29–31, 2009.

  36. Sica DA: Baroreflex activation in drug-resistant hypertension. US Cardiol 2009, 5(I):29–32.

    Google Scholar 

  37. Young K, Teeters J, Benesch C, et al.: Cost-effectiveness of treating resistant hypertension with an implantable carotid body stimulator. J Clin Hypertens 2009, 11:555–563.

    Article  Google Scholar 

  38. Textor SC: What price for blood pressure control? J Clin Hypertens 2009, 11:537–539.

    Article  Google Scholar 

  39. Sabbah HN, Imai M, Irwin E, et al.: Chronic electrical activation of the carotid baroreflex improves left ventricular systolic and diastolic function in dogs with advanced heart failure [abstract]. Circulation 2005, 112(17-II):557.

    Google Scholar 

  40. Zucker IH, Hackley JF, Cornish KG, et al.: Chronic baroreceptor activation enhances survival in dogs with pacing-induced heart failure. Hypertension 2007, 50:904–910.

    Article  CAS  PubMed  Google Scholar 

  41. Gupta RC, Mishra S, Irwin ED, et al.: Chronic reflex activation therapy normalized gene expression of nitric oxide synthetase in left ventricular myocardium of dogs with chronic heart failure [abstract]. J Am Coll Cardiol 2007, 49(Suppl 9):86A.

    Google Scholar 

  42. Bisognano JD, De Leeuw P, Bach DS, et al.: Improved functional capacity and cardiovascular structure after baroreflex activation therapy in resistant hypertension patients with symptomatic heart failure : Results from European and United States trials of Rheos® System. J Card Failure 2009, 15(6):S63.

    Article  Google Scholar 

  43. de Leeuw P, Bisognano JD, Bach BS, et al.: Improved myocardial energetics following chronic treatment using an implantable device in resistant hypertension: results from European and United States trials of Rheos® System. Circulation 2009, 120:S1005.

    Google Scholar 

  44. Bisognano J, de Leeuw P, Irwin E, et al. : Reduced arrhythmia burden in a resistant hypertensive patient receiving baroreflex activation therapy from an implantable device. Heart Rhythm 2009, 6(5):S327.

    Google Scholar 

  45. • CVRx, Inc. Available at http://www.cvrx.com/medpros/index.php?id=16&parentid=16. Accessed November 2009. This website provides detailed and up-to-date information on the BHT system, with links to key publications.

Download references

Disclosure

Dr. Bisognano is a consultant for CVRx, Inc. No other potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Cardiology Division, University of Rochester, 601 Elmwood Avenue, Box 679-7, Rochester, NY, 14642-8679, USA

    John D. Bisognano

  2. Department of Internal Medicine, Nephrology Division, University of Rochester, 601 Elmwood Avenue, Box 679-7, Rochester, NY, 14642-8679, USA

    Jeremy G. Taylor

Authors
  1. Jeremy G. Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John D. Bisognano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John D. Bisognano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taylor, J.G., Bisognano, J.D. Baroreflex Stimulation in Antihypertensive Treatment. Curr Hypertens Rep 12, 176–181 (2010). https://doi.org/10.1007/s11906-010-0106-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-010-0106-6

Keywords

Search

Navigation